Filgotinib

From WikiMD.org
Jump to navigation Jump to search

Filgotinib (pronounced as fil-go-ti-nib) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other autoimmune diseases.

Etymology

The name "Filgotinib" is derived from the name of the company that developed it, Galapagos NV, and the class of drugs it belongs to, known as Janus kinase inhibitors.

Pronunciation

The pronunciation of Filgotinib is "fil-go-ti-nib".

Medical Uses

Filgotinib is used in the treatment of moderate to severe rheumatoid arthritis in adults who have not responded well to one or more disease-modifying antirheumatic drugs (DMARDs). It is also being studied for its potential use in the treatment of other autoimmune diseases, including ulcerative colitis and Crohn's disease.

Mechanism of Action

Filgotinib works by inhibiting Janus kinase enzymes, which play a crucial role in the immune response. By blocking these enzymes, Filgotinib can help to reduce inflammation and slow the progression of autoimmune diseases.

Side Effects

Common side effects of Filgotinib include nausea, diarrhea, and upper respiratory tract infection. Serious side effects may include blood clots, cancer, and serious infections.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski